BioCryst Pharmaceuticals
BCRX
BCRX
98 hedge funds and large institutions have $588M invested in BioCryst Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 91 → 98 (+7)
20% less capital invested
Capital invested by funds: $739M → $588M (-$151M)
Holders
98
Holding in Top 10
5
Calls
$3.96M
Puts
$2.85M
Top Buyers
| 1 | +$21.1M | |
| 2 | +$8.79M | |
| 3 | +$6.99M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.97M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| 1 | -$3.33M | |
| 2 | -$3.22M | |
| 3 | -$2.48M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.23M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.13M |